[DPHARMA] YoY TTM Result on 30-Jun-2015 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Aug-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Jun-2015 [#2]
Profit Trend
QoQ- -4.59%
YoY- 8.26%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 484,882 394,690 327,738 197,750 167,697 140,724 140,215 22.96%
PBT 53,202 38,579 46,824 45,813 39,496 39,354 35,468 6.98%
Tax -9,321 -3,626 -11,087 -8,393 -7,519 -9,526 -8,043 2.48%
NP 43,881 34,953 35,737 37,420 31,977 29,828 27,425 8.14%
-
NP to SH 44,396 35,484 36,314 34,618 31,977 29,828 27,425 8.35%
-
Tax Rate 17.52% 9.40% 23.68% 18.32% 19.04% 24.21% 22.68% -
Total Cost 441,001 359,737 292,001 160,330 135,720 110,896 112,790 25.50%
-
Net Worth 209,983 463,071 510,978 189,815 179,145 187,404 162,310 4.38%
Dividend
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Div 20,937 7,085 8,084 25,710 24,291 20,128 24,980 -2.89%
Div Payout % 47.16% 19.97% 22.26% 74.27% 75.97% 67.48% 91.09% -
Equity
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Net Worth 209,983 463,071 510,978 189,815 179,145 187,404 162,310 4.38%
NOSH 650,902 278,959 278,959 139,570 138,872 138,818 138,727 29.37%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin 9.05% 8.86% 10.90% 18.92% 19.07% 21.20% 19.56% -
ROE 21.14% 7.66% 7.11% 18.24% 17.85% 15.92% 16.90% -
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
RPS 173.19 141.49 102.62 141.68 120.76 101.37 101.07 9.38%
EPS 15.86 12.72 11.37 24.80 23.03 21.49 19.77 -3.60%
DPS 7.50 2.54 2.53 18.50 17.50 14.50 18.00 -13.57%
NAPS 0.75 1.66 1.60 1.36 1.29 1.35 1.17 -7.14%
Adjusted Per Share Value based on latest NOSH - 139,570
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
RPS 50.37 41.00 34.05 20.54 17.42 14.62 14.57 22.95%
EPS 4.61 3.69 3.77 3.60 3.32 3.10 2.85 8.34%
DPS 2.17 0.74 0.84 2.67 2.52 2.09 2.59 -2.90%
NAPS 0.2181 0.481 0.5308 0.1972 0.1861 0.1947 0.1686 4.38%
Price Multiplier on Financial Quarter End Date
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Date 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 -
Price 1.30 2.25 2.04 2.65 2.97 2.38 2.23 -
P/RPS 0.75 1.59 1.99 1.87 2.46 2.35 2.21 -16.47%
P/EPS 8.20 17.69 17.94 10.68 12.90 11.08 11.28 -5.17%
EY 12.20 5.65 5.57 9.36 7.75 9.03 8.87 5.45%
DY 5.77 1.13 1.24 6.98 5.89 6.09 8.07 -5.43%
P/NAPS 1.73 1.36 1.28 1.95 2.30 1.76 1.91 -1.63%
Price Multiplier on Announcement Date
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Date 26/11/18 25/08/17 22/08/16 25/08/15 26/08/14 28/08/13 16/08/12 -
Price 1.08 2.03 2.14 2.40 3.37 2.44 2.38 -
P/RPS 0.62 1.43 2.09 1.69 2.79 2.41 2.35 -19.90%
P/EPS 6.81 15.96 18.82 9.68 14.64 11.36 12.04 -9.05%
EY 14.68 6.27 5.31 10.33 6.83 8.81 8.31 9.94%
DY 6.94 1.25 1.18 7.71 5.19 5.94 7.56 -1.41%
P/NAPS 1.44 1.22 1.34 1.76 2.61 1.81 2.03 -5.56%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment